Why Is the Continuous Glucose Monitoring Market Transforming Diabetes Management

The Global Continuous Glucose Monitoring Market reached US$ 13.18 billion in 2025 and is expected to reach US$ 41.11 billion by 2033, growing with a CAGR of 14.8% during the forecast period 2026-2033. Growth is driven by the increasing prevalence of diabetes and rising demand for real-time glucose monitoring solutions. Growing awareness of diabetes management and preventive healthcare is accelerating market adoption. The integration of CGM devices with smartphones, insulin pumps, and digital health platforms is further supporting market expansion. Additionally, advancements in sensor accuracy, wearability, and connectivity are improving patient outcomes. Expanding healthcare access and favorable reimbursement policies are also contributing to strong market growth.

Download PDF Sample Report:
https://www.datamintelligence.com/download-sample/continuous-glucose-monitoring-market?prasad

United States: Recent Developments

✅ In June 2026, Dexcom expanded its Continuous Glucose Monitoring portfolio with enhanced AI-powered glucose insights and digital health integration. The development improves diabetes management and patient engagement.

✅ In May 2026, Abbott strengthened its FreeStyle Libre ecosystem with expanded digital connectivity and remote monitoring capabilities. The innovation enhances real-time glucose management.

✅ In April 2026, Medtronic improved its CGM technologies with enhanced sensor accuracy and integrated insulin delivery compatibility. The development supports personalized diabetes care.

✅ In April 2026, Senseonics Holdings expanded its implantable CGM platform with improved sensor longevity and mobile health connectivity. The innovation strengthens long-term glucose monitoring.

Japan: Recent Developments

✅ In June 2026, Terumo Corporation expanded its diabetes management portfolio with improved glucose monitoring technologies supporting digital healthcare. The development enhances patient care.

✅ In May 2026, Arkray, Inc. enhanced its continuous glucose monitoring solutions with improved sensor performance and connectivity. The innovation supports better diabetes management.

✅ In April 2026, Nipro Corporation strengthened its diabetes care portfolio through advanced glucose monitoring technologies for home healthcare applications. The development improves treatment accessibility.

✅ In April 2026, A&D Company, Ltd. expanded digital diabetes monitoring solutions with enhanced data integration supporting remote patient management. The initiative strengthens connected healthcare.

Purchase the Exclusive Report:
https://www.datamintelligence.com/buy-now-page?report=continuous-glucose-monitoring-market?prasad

Continuous Glucose Monitoring Market Major Players:

Abbott Laboratories

Abbott Laboratories is a global leader in the continuous glucose monitoring (CGM) market, driven by its widely adopted FreeStyle Libre portfolio. In 2025, the company reported revenue of USD 42.0 billion, supported by diagnostics, medical devices, nutrition, and established pharmaceuticals. In the continuous glucose monitoring market, Abbott plays a major role by offering factory-calibrated, wearable CGM sensors that provide real-time glucose readings, smartphone connectivity, and remote monitoring capabilities. Its solutions help individuals with diabetes improve glycemic control and support informed treatment decisions.

DexCom, Inc.

Dexcom is one of the world's leading manufacturers of continuous glucose monitoring systems, focusing on real-time glucose monitoring for diabetes management. In 2025, the company reported revenue of USD 4.8 billion, driven by strong global adoption of its CGM platforms. In the continuous glucose monitoring market, Dexcom plays a key role through its advanced wearable CGM systems, offering continuous real-time glucose data, predictive alerts, and seamless integration with insulin pumps, smartphones, and digital health platforms to enhance diabetes care and patient outcomes.

A. Menarini Diagnostics S.r.l.

A. Menarini Diagnostics is a leading provider of diabetes management and diagnostic solutions with a growing presence in the continuous glucose monitoring market. In 2025, the company reported revenue of USD 0.9 billion, driven by diabetes diagnostics, point-of-care testing, and laboratory solutions. In the continuous glucose monitoring market, Menarini plays a significant role by offering CGM devices and integrated diabetes management solutions that enable continuous glucose tracking, improve treatment decisions, and support personalized diabetes care across clinical and home settings.

Echo Therapeutics, Inc.

Echo Therapeutics is a medical technology company developing innovative glucose monitoring solutions for diabetes management. In 2025, the company reported revenue of USD 0.03 billion, driven by research, development, and commercialization of glucose monitoring technologies. In the continuous glucose monitoring market, Echo Therapeutics plays a niche role by developing minimally invasive and non-invasive continuous glucose monitoring systems designed to improve patient comfort, enable real-time glucose measurement, and support better long-term diabetes management through continuous data collection.

Find the Right Partner to Accelerate Your Growth Today with Our Latest Report:
https://www.datamintelligence.com/partner-identification-enquiry/continuous-glucose-monitoring-market?prasad

Segment Covered in the Continuous Glucose Monitoring Market:

By Component: Sensors
Sensors dominate the continuous glucose monitoring (CGM) market as they are the core consumable component responsible for continuously measuring glucose levels in interstitial fluid. Since sensors require regular replacement, they generate recurring revenue and account for the largest share of the market. Advancements in sensor accuracy, wear duration, and patient comfort continue to drive their widespread adoption.
The sensors segment accounts for approximately 53% of the total market. Based on a global market size assumption of USD 12.8 billion in 2025, this translates to an estimated segment value of USD 6.78 billion. Growth is driven by increasing diabetes prevalence, expanding reimbursement coverage, and rising adoption of wearable diabetes management technologies.

By End User: Home Healthcare
Home healthcare represents the largest end-user segment due to the increasing preference for self-monitoring of glucose levels, growing adoption of wearable CGM devices, and the shift toward patient-centered diabetes management. Continuous glucose monitoring enables real-time glucose tracking without frequent finger-stick testing, making it particularly suitable for home-based care.
The home healthcare segment accounts for approximately 69% of the total market. Based on the USD 12.8 billion global market size in 2025, this corresponds to an estimated value of USD 8.83 billion. Growth is driven by rising awareness of diabetes management, increasing use of connected health devices, and expanding telehealth and remote patient monitoring services.

Market Segmentation
The Continuous Glucose Monitoring Market is segmented by component into transmitter, receiver, sensor, insulin pumps, and others; and by end user into diagnostic centers, ICUs, and home healthcare.

Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/continuous-glucose-monitoring-market?prasad

Regional Analysis

North America
North America is the leading continuous glucose monitoring market due to the high prevalence of diabetes, favorable reimbursement policies, strong adoption of wearable medical devices, and advanced healthcare infrastructure. The region is led by the United States, where increasing awareness of diabetes management and continuous technological innovations continue to support market growth.
The North American market is estimated at approximately USD 5.50 billion in 2025, accounting for about 43% of the global market. Growth is driven by increasing adoption of real-time CGM systems, expanding insurance coverage, and growing integration of CGM devices with insulin delivery systems.

Europe
Europe is a major market supported by rising diabetes prevalence, increasing adoption of digital healthcare technologies, and expanding reimbursement for CGM devices. Key contributors include Germany, United Kingdom, and France.
The European market is valued at approximately USD 3.58 billion in 2025, representing about 28% of the global market. Growth is driven by improving access to diabetes technologies, increasing patient awareness, and supportive government healthcare initiatives.

Asia Pacific
Asia Pacific is the fastest-growing continuous glucose monitoring market due to the rapidly increasing diabetic population, improving healthcare infrastructure, and rising adoption of wearable health monitoring devices. Major markets include China, Japan, India, and South Korea.
The region is valued at approximately USD 3.71 billion in 2025, accounting for about 29% of the global market. Growth is driven by increasing healthcare expenditure, expanding diabetes screening programs, growing availability of CGM devices, and rising investments in digital health technologies.

Data-Driven Research Methodology for the Continuous Glucose Monitoring Market:

Our research process for the Continuous Glucose Monitoring Market at DataM Intelligence combines rigorous primary and secondary research to ensure accurate and reliable insights. We engage with industry experts, key stakeholders, and validated data sources to capture real-time market dynamics. Advanced analytical tools and proprietary models are applied to forecast trends, competitive landscapes, and growth opportunities. Each report undergoes multi-level validation to deliver actionable intelligence that supports strategic decision-making.

For More Information@ https://www.datamintelligence.com/research-report/continuous-glucose-monitoring-market

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Contact Us-
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: fabian@datamintelligence.com

About Us
DataM Intelligence is a market research and consulting firm that delivers comprehensive end-to-end business solutions, covering everything from in-depth research to strategic consulting. The company leverages key industry trends, insights, and developments to provide fast, reliable, and actionable solutions tailored to diverse client requirements.
It offers both syndicated and customized research reports supported by a strong and robust methodology. With an extensive database comprising 9000+ reports across 40+ industry domains, DataM Intelligence serves over 200 companies in more than 50 countries, helping organizations access critical business intelligence that drives informed decision-making and sustainable growth.

This release was published on openPR.